The purpose of this study is to characterize the natural history of DRPLA patients using a variety of clinical and biomarker modalities and to identify genetic factors, biomarkers, and clinical measures that could predict disease progression.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
Yael Shiloh-Malawsky
Neurology
Clinical or Medical
Observational
Genetics and Genetic Disorders
Healthy Volunteer or General Population
Rare Diseases
21-1334
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
